|
| |
Evaluation of memantine for neuroprotection
in dementia.
Jain KK.
Jain PharmaBiotech,
Blasiring 7, CH-4057 Basel, Switzerland.
jain@pharmabiotech.ch.
Expert Opin Investig Drugs 2000 Jun;9(6):1397-406
Abstract
Memantine, a non-competitive NMDA antagonist, has been approved for use in the treatment of dementia in Germany for over ten years. The rationale for use is excitotoxicity as a pathomechanism of neurodegenerative disorders. Memantine acts as a neuroprotective agent against this pathomechanism, which is also implicated in vascular dementia. HIV-1 proteins Tat and gp120 have been implicated in the pathogenesis of dementia associated with HIV infection and the neurotoxicity caused by HIV-1 proteins can be blocked completely by memantine. Memantine has been investigated extensively in animal studies and following this, its efficacy and safety has been established and confirmed by clinical experience in humans. It exhibits none of the undesirable effects associated with competitive NMDA antagonists such as dizocilpine. The efficacy of memantine in a variety of dementias has been shown in clinical trials. Memantine is considered to be a promising neuroprotective drug for the treatment of dementias, particularly Alzheimer's disease for which there is no neuroprotective therapy available currently. It can be combined with acetylcholinesterase inhibitors which are the mainstay of current symptomatic treatment of Alzheimer's disease. Memantine has a therapeutic potential in numerous CNS disorders besides dementias which include stroke, CNS trauma, Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), epilepsy, drug dependence and chronic pain. If memantine is approved by the FDA for some of these indications by the year 2005, it can become a blockbuster drug by crossing the US$1 billion mark in annual sales.
|
|
|
order |
|
Galantamine Alzheimer's
articles
www.AlzheimersTreatments.com
Galantamine fights Alzheimer's
In
the 1950s, a Bulgarian pharmacologist noticed that local villagers rubbed their
foreheads with
the snowdrop plant to ease
nerve pain. Further investigation led to the isolation of the snowdrop extract
galantamine continue
Galantamine: why galantamine is the best agent for restoring memory
Galantamine has several advantages over donepezil (Aricept®) and rivastigmine (Exelon®)
continue
Galantamine: can sharpen your mental edge
Galantamine's positive results
in slowing the progression of Alzheimer's disease may be due continue
Galantamine: helps save Memory
Galantamine is used in treating Alzheimer's disease, because of its ability
continue
Galantamine: beats Prescription Drugs for
combating Mental Decline
Galantamine is different from donepezil (Aricept®) and rivastigmine (Exelon®) in one very important
way, galantamine has the unique ability to increase the receptiveness of nicotinic
receptors to acetylcholine continue
Galantamine: opens the channels of your Memory
The secret
of galantamine's success lies in your brain's nicotinic receptors. continue
Galantamine: Protect Brain Function by Enhancing Neurotransmission
Galantamine has been found to be effective in treating Alzheimer's
disease continue
Galantamine:
Boost Memory
Galantamine achieves the same effect as drugs such as
Aricept or tacrine, but has additional benefits continue
Galantamine protects Brain funtion
The
primary objective with
Alzheimer's is to enhance neurotransmission so as to retain memory continue
Galantamine:
food for Mind & Body
Galantamine is a
flower extract that improves memory and perhaps even helps with impotence continue
Galantamine may help stave off Dementia
Dementia
is a progressive loss of memory accompanied by significant continue
Galantamine: Memory Enhancement
Alzheimer's patients suffer sharp declines in their brain levels of acetylcholine.
Galantamine continue
Galantamine rescues
Brain Cells
According to a study of 653 Alzheimer's disease
patients published in the
British Medical Journal, the herbal supplement galantamine
"appears to slow the progression of the neurodegenerative
condition" continue
Galantamine:
the Old Become Young
As we age, it becomes harder to
learn new things. One explanation is the deterioration of the brain's
continue
Galantamine: What's Old with Acetylcholine is New to Us
Acetylcholine
deficiency is
characteristic of Alzheimer's disease. The primary treatment is administration
of agents like galantamine, an extract from the snowdrop and
daffodil plants continue
|
|